ArticleDrug and alcohol review2019
Medical and non-medical cannabis use and risk of prescription opioid use disorder: Findings from propensity score matching.
Article in Drug and alcohol review, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Brief report: Are changes in cannabis use frequency associated with changes in alcohol use and smoking among people with HIV (PWH) - A substitution question.Drug and alcohol dependence · 2025Article
- Cannabis Legalization and Opioid Use Disorder in Veterans Health Administration Patients.JAMA health forum · 2025Article
- Co-use of opioids and cannabis versus single-substance use: a national analysis of US adults.Frontiers in public health · 2025Article
- Indirect effects of emotion regulation in the relationship between pain and cannabis use in adults 18-64 years.Addictive behaviors · 2024Article
- The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder.Pain and therapy · 2024Review
- The association between cannabis use and risk of non-medical pain reliever misuse onset among young adults in a legal cannabis context.Addictive behaviors · 2023Article
- Recreational cannabis legalization and transitions in cannabis use: findings from a nationally representative longitudinal cohort in the United States.Addiction (Abingdon, England) · 2022Article
- Strategies aimed at preventing long-term opioid use in trauma and orthopaedic surgery: a scoping review.BMC musculoskeletal disorders · 2022Article
- Nationwide Population-Based Study About Patterns of Prescription Opioid Use and Misuse Among Young Adults in Spain.International journal of public health · 2022Article
- Abuse-deterrent extended-release oxycodone and risk of opioid-related harm.Addiction (Abingdon, England) · 2021Article
- Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017-2019.Harm reduction journal · 2021Article
- Positive Toxicology Results Are Not Associated with Emergency Physicians' Opioid Prescribing Behavior.The western journal of emergency medicine · 2021Article
- [The green rush-worse than feared? : Data on the misuse of medical cannabis].Schmerz (Berlin, Germany) · 2021Article
- The associations of medical marijuana policies with opioid-related health care utilization.Health services research · 2021Article
- Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.BMJ (Clinical research ed.) · 2021Article
- Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review.Journal of clinical medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
INTRODUCTION AND
aimsPrevious research suggested that cannabis use was associated with increased risks of prescription opioid misuse and use disorder. This study examined whether these associations differed by cannabis use purpose. DESIGN AND
methodsThis is a secondary analysis of cross-sectional surveys with propensity score matching. Medical cannabis users (N = 1295), cannabis dual users with both medical and non-medical purposes (N = 707) and non-medical cannabis users (N = 18 666) were compared with cannabis non-users (N = 57 196) in the pooled 2013-2016 US nationally representative National Survey on Drug Use and Health. Propensity score models were applied to match cannabis non-users to cannabis users with different purposes with respect to potential confounders in individual socioeconomic characteristics, other substance use disorders and health conditions. In a matched sample, logistic regressions were used to assess associations.
resultsPropensity score matching considerably improved the balance of the potential confounders between cannabis non-users and users. In a matched sample, non-medical cannabis use was associated with increased risks of prescription opioid misuse (OR = 3.15, 95%CI: 2.89-3.44) and use disorder (OR = 2.52, 95%CI: 2.06-3.10). Cannabis dual use and medical cannabis use were associated with increased risks of prescription opioid misuse (OR = 2.55, 95%CI: 1.78-3.65; OR = 2.15, 95%CI: 1.58-2.91, respectively), but they were not associated with prescription opioid use disorder. DISCUSSION AND
conclusionsMedical and non-medical cannabis use both were both associated with increased risks of prescription opioid misuse. Medical cannabis use, however, was not associated with prescription opioid use disorder, and non-medical cannabis was. There appeared to be differential associations between cannabis use and prescription opioid use disorder by cannabis use purpose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.